GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood pressure drug tested to stop transplant complication
Disease control TerminatedThis study tested whether the blood pressure drug telmisartan could prevent acute graft-versus-host disease (GVHD) in 32 people with blood cancers receiving a stem cell transplant. GVHD is a serious complication where donor cells attack the patient's body. The trial was stopped e…
Matched conditions: GVHD
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New hope for gut GVHD? trial tests apraglutide in Steroid-Resistant patients
Disease control TerminatedThis study tested a drug called apraglutide in people who had severe gut graft-versus-host disease (GVHD) after a stem cell transplant and did not respond to steroids. The goal was to see if the drug is safe and helps control the disease. The trial was stopped early and included …
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: VectivBio AG • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC